Shares of Oracle (ORCL) jumped about 9% on Wednesday after the IT giant reported fiscal third-quarter results and guidance that topped Wall Street's estimates. In light of this, below is a list of ...

Analysts across Wall Street were happy after Oracle delivered stronger-than-expected fiscal third-quarter results , with accelerating cloud infrastructure growth helping ease concerns about the scale ...

Oracle shares surged about 12% on Wednesday after the software giant's upbeat revenue forecast eased concerns over its hefty spending on artificial intelligence ​infrastructure.

Live Updates Conference Call Highlights 18 hours ago Here’s the key highlights from Oracle’s conference call: First 20/20 ...

Free cash flow at the enterprise software giant has tumbled over the past year as the company races to spend $50 billion on ...

Oracle posted earnings that topped Wall Street estimates and lifted its outlook, as strong AI demand drove its sales and backlog to record highs.

Oracle on Tuesday predicted that the AI data ​center boom will power its revenue above Wall Street estimates well into 2027, sending its shares up 8.3% in extended trading.

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

The likelihood that Nvidia NVDA-0.55%decrease; red down pointing triangle will be investing far less than $100 billion in OpenAI raises big questions for Oracle ORCL 0.63%increase; green up pointing ...

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. Oracle burned through $10 billion in cash in its most recent ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.